Summary
Guardant Health, Inc. (GH) filed an 8-K on November 7, 2019, to announce its financial results for the fiscal quarter ended September 30, 2019. The primary focus of this filing is the press release included as Exhibit 99.1, which details the company's performance. Investors should pay close attention to the revenue, net loss, and any forward-looking guidance provided within this press release to assess the company's operational and financial standing during the period. While the 8-K itself is a standard filing to report these results, the substance for investors lies in the accompanying press release. This document typically contains key performance indicators, such as revenue growth, profitability metrics, and updates on product development or commercialization efforts. The market reaction to these reported results and any commentary from management will be critical in understanding investor sentiment and the outlook for Guardant Health.
Key Highlights
- 1Guardant Health announced its financial results for the third quarter ended September 30, 2019.
- 2The press release containing the financial results is furnished as Exhibit 99.1 to the 8-K.
- 3The filing incorporates the press release by reference, making its contents crucial for investor analysis.
- 4This report serves as the official notification of the company's quarterly financial performance.
- 5Information furnished under Item 2.02 is typically not considered 'filed' for Section 18 liability purposes, but is still material for investors.
- 6Investors should refer to Exhibit 99.1 for specific financial figures and operational updates.